UNC Urology’s Hung-Jui (Ray) Tan, MD, MSHPM and Soohyun Hwang, MPH, a PhD Candidate in the Department of Health Policy and Management have been awarded a pilot grant sponsored by Advancing Cancer Treatment (ACT).
“While active surveillance has become a recommended management strategy for patients with low-risk prostate cancer, the rates of implementation of this strategy and patient adherence are highly variable. We plan to use data from SEER-Medicare with the hopes of better understanding this variation and any overarching social determinants for utilizing active surveillance.”
Soohyun Hwang, MPH
PhD Candidate, Department of Health Policy and Management
University of North Carolina Gillings School of Global Public Health
Hung-Jui (Ray) Tan, MD, MSHPM
Urologic Oncology Fellowship Program Director
Assistant Professor of Urology
About Advancing Caner Treatment (ACT)
Advancing Cancer Treatment (ACT) is a philanthropic initiative designed to improve access to clinical trials for cancer patients. The hypothesis is that both grant support and public recognition will help alter public opinion toward clinical trials and encourage participating programs to learn from one another.
ACT also provides awards to publicly promote best practices and innovative solutions by organizations, institutions, and physicians that demonstrate increased patient access to clinical trials and illuminate the benefits of these trials as first line therapy. The current focus is on improving accrual to prostate cancer clinical trials.